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Background Queensland has the highest incidence of Q fever in
Australia. The aim of this study was to undertake a cross-sectional
seroprevalence survey of Coxiella burnetii, the causative agent of
Q fever, in beef cattle in Queensland.
Methods Serum samples were tested by ELISA for both phase II
and phase I antigens of the organism using an Australian isolate.
Blood samples were collected at an abattoir that processes beef
cattle originating from northern and north-western Queensland, in
addition to blood samples taken from beef cattle across Queen-
sland as part of a second survey.
Results Seropositivity was 16.8% (95% confidence interval 16.7–
16.8%).
Conclusion Evidence of C. burnetii infection in beef cattle has
public health implications for occupational exposure of primary
producers and veterinarians and for the proximity of beef cattle
properties to residential areas in regional Queensland. This study is
the first known investigation of C. burnetii seroprevalence in beef
cattle in Queensland and the first known use of an Australian
C. burnetii isolate for screening using both phase II and phase I
antigens.
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Abbreviations CI, confidence interval; ddH2O, double-distilled
water; ELISA, enzyme-linked immunosorbent assay; Ig, immunoglo-
bulin; LPS, lipopolysaccharide; OD, optical density; PBS, phosphate-
buffered saline
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Qfever is a worldwide zoonosis caused by Coxiella burnetii,an obligate intracellular bacterium.1 In animals the infectionis referred to as coxiellosis. The organism is ubiquitous,
with a geographical spread extending worldwide, with the exception
of New Zealand.2 Coxiella burnetii exists in two antigenically different
phases, which are characterised by transition of lipopolysaccharide
(LPS) from a smooth form with full-length O-side chains in phase I to
a rough form with truncated O-side chains in phase II. In humans,
differences in the titres of immunoglobulin (Ig) subsets to phase I or
II antigens form the basis for diagnosis of acute (antibodies to phase II
antigens) or chronic (antibodies to phase I antigens) Q fever.1 It has
been demonstrated that animals infected with C. burnetii produce
antibodies to both phase I and phase II antigens.3 Most commercial
animal Q fever enzyme-linked immunosorbent assays (ELISAs)
consist of a mixture of phase I and phase II antigens.
The domestic reservoir, consisting of cattle, sheep and goats, is con-
sidered the major source of transmission of C. burnetii infection to
humans in Australia. Coxiella burnetii is thought to be initially trans-
mitted to livestock via ticks, which form part of the natural transmis-
sion cycle of the organism in wildlife. Kangaroos4,5 and bandicoots6
have been identified as potential reservoirs of Q fever in Australia.
Human infection is usually acquired by inhalation of contaminated
material from infected animals. Less commonly, infection may result
from consumption of infected animal products, such as unpasteurised
milk.Very rarely, it may result via sexual transmission following expo-
sure to infected body fluids.7 Those most at risk of Q fever infection
include individuals with occupational contact with reservoir animals,
particularly those in the meat and livestock industries, veterinarians
and laboratory workers.1 The organism is capable of long-term envi-
ronmental persistence, it being suggested but not conclusively shown
that this persistence may be in a spore-like form.1 As a result of
environmental contamination, a number of outbreaks of Q fever are
reported to have occurred following strong winds blowing through
areas where livestock are bred, held or transported.8,9
Since 1934, when sporadic cases of fever with a typhoid-like presen-
tation became apparent to medical practitioners in Brisbane, out-
breaks of Q fever in Australia have been predominantly associated
with abattoirs.10 In a recent series of cases over a 20-year period in
southern Australia, 92% of the 111 cases of Q fever were among
abattoir workers.11 In North Queensland, a study of Q fever cases
during 1994–2006, found that 22% of acute and 33% of chronic
Q fever patients reported exposure to cattle.12 This trend extends
internationally, where an occupation in the meat-processing indus-
tries has been associated with increased risk of Q fever infection.1
Infections in animals are usually subclinical, although infection can be
associated with abortions and reproductive disorders.13–15 Seropositiv-
ity is believed to be seasonal in livestock, particularly sheep, as sero-
logical studies indicate the presence of recurring annual cycles of
antibody prevalence in response to C. burnetii exposure during lamb-
ing.16 More recent studies in dairy cattle indicate that seropositivity is
related to changes in endocrine patterns during gestation.17 However,
these studies were performed overseas and no comparable data are
available for Australia.
In epidemiological studies during the past 6 years, the seroprevalence
ofC.burnetii in cattle populations has varied according to geographical
location: 6.2% in Northern Ireland,18 87.9% in Albania,19 10.75% in
Iran,20 14.3% in theCentralAfricanRepublic,21 24% inNewfoundland22
and Cyprus23 and 25.6% in Korea.24 Previous serological investigations
of the prevalence of C. burnetii infection in Australian cattle
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demonstrated it was not common in beef cattle inWestern Australia4
and South Australia,25 dairy cattle in Victoria26 or beef and dairy cattle
in New SouthWales,27 with seroprevalence in all four studies found to
be>1%.Although the incidence of Q fever in humans ismuchhigher in
Queensland compared with the other states,28 no record of serological
surveys performed on beef cattle in Queensland has been found.
Queensland has the largest beef cattle herd in Australia and is also the
largest producer and exporter of beef cattle.29 Beef cattle production
represents the largest agricultural industry in the state and was valued
at A$3.4 billion in 2007–08.30 The Queensland beef cattle herd is
estimated to be 12.2 million head, 96% of which is managed on 14,568
specialised beef cattle properties.29
To determine the risk of microbial infection, the sources of potential
infection and routes of transmission must be identified. Conse-
quences associated with a lack of such knowledge were highlighted
when an outbreak of Q fever occurred at an Australian abattoir
slaughtering feral goats.31 Poor understanding of both the transmis-
sion of C. burnetii and the potential for goats as a reservoir resulted in
a failure to use methods of reducing the production of aerosols. The
capacity to identify such potential sources of Q fever infection in
Australia, particularly in the tropical north, is compromised by the
lack of data regarding reservoir populations. The aims of this study
were to undertake a serological survey to establish the prevalence of




Blood samples were obtained immediately following slaughter of beef
cattle at an abattoir in the Townsville Shire District of Northern
Queensland. The catchment area of this abattoir includes the regions
of northern, far-northern and north-western Queensland, as well as
the Northern Territory. The abattoir has a daily processing capacity of
900 beasts. Samples (n = 730) were collected during 2006–07 on four
separate occasions, approximately 6 months apart, with 150–200
samples collected randomly on each occasion. Samples were stratified
by cattle property to ensure a representative spectrum of the northern
Queensland beef industry was covered, with animals originating
from 17 different cattle properties in 8 districts. Only properties with
greater than 10 samples were included in the statistical analyses.
A further set of samples was obtained from a collection of randomly
selected samples (n = 1344) taken from breeders and heifers originat-
ing from 46 different Queensland beef cattle properties in 24 districts
during 2008–09. A statistically valid sample size was calculated for
each property based on the total number of cattle present in eachmob.
Serum was separated from each blood sample by centrifugation and
stored at -20°C.
Preparation of ELISA antigens
Antigen was prepared according to a protocol described elsewhere.32
Both phase I and phase II C. burnetii antigens were produced using
an Australian C. burnetii isolate (Cumberland strain). This isolate
was obtained from the Australian Rickettsial Reference Laboratory,
Geelong, Victoria, and came from a patient who contracted Q fever
through contact with beef cattle. Phase II C. burnetii was obtained by
serial passage in Vero cell culture to a total of 15 passages. Cell sus-
pensions and supernatants were pooled and centrifuged at 1000g at
20°C for 10 min. Supernatants were discarded and the cells resus-
pended in phosphate-buffered saline (PBS), pH 7.4. Host cells were
disrupted by sonication and bacteria were separated from cell debris
by centrifugation at 550g at 20°C for 10 min. The resultant superna-
tant was layered over 25% sucrose and centrifuged at 4500g at 20°C for
20 min. The supernatant was discarded and the C. burnetii resus-
pended in PBS, pH 7.4. The bacteria were inactivated with 1% forma-
lin for 48 h at 4°C. Inactivated C. burnetii were pelleted at 10,000g at
20°C for 10 min and washed three times in sterile double-distilled
water (ddH2O). The inactivated cells were resuspended in sterile
ddH2O, after which they were referred to as whole cell antigen.
Phase I antigen was produced via animal passage in A/J strain mice,
followed by a single passage in the yolk sac of embryonated chicken
eggs.Mice were inoculated with 1 ¥ 104 C. burnetii IP and maintained
for 7 days prior to euthanasia by CO2 asphyxiation. The spleens were
harvested for bacterial extraction as described for phase II antigen.
Animal passage was carried out under approval of the James Cook
University Animal Ethics Committee under PC3 conditions (A1139).
Bacteria were separated from egg yolk and formalin-inactivated as
described for phase II antigen.
Phase I and II antigenicity was confirmed by complement block titra-
tion using commercial anti-C. burnetii phase II and I control sera
and antigens (Virion/Serion, Germany). The commercially available
phase I and II C. burnetii antigen and control sera were initially used
for comparison and quality control of the prepared antigen. Absor-
bance values for control sera against commercial antigen were com-
parable to those obtained with control sera against in-house prepared
ELISA antigen. The ELISA was initially optimised and validated using
serum from C57Bl/6 mice experimentally infected with C. burnetii
and PBS-inoculated negative controls, carried out under approval of
the James Cook University Animal Ethics Committee under PC3 con-
ditions (A1139).
Bovine screening ELISA
The screening ELISA used an indirect design of separately coating the
wells of NUNC™ Maxisorp plates with the phase I and phase II
antigens.Plates were coated with antigen at 50 mg/mL and incubated at
room temperature overnight in a humidified chamber.The plates were
then blocked and stabilised with 100 mL of post-coating buffer (Trop-
Bio,QLD,Australia), incubated at room temperature for 2 h,before the
supernatant was removed and the plates dried. Plates were then sealed
for later use. Coated plates were incubated with 50 mL aliquots of the
animal serum to be tested at 1/100 dilutions and left to incubate at 37°C
for 1 h.The plates were washedwith PBS and 0.05%Tween 20 and then
50 mL 1/1,000 rabbit anti-bovine Ig-horseradish peroxidase conjugate
(Serotec,NSW,Australia) was added to each well and left to incubate at
37°C for 1 h. The plates were washed again and 100 mL of ABTS was
added to each well and left to incubate at 37°C for 30 min. The optical
density (OD) at 414–494 nm was then determined using a Multiskan
EX (Labsystems) plate reader. Initially, 30 samples were randomly
selected and tested as described. Five high-reacting samples and five
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negative control sera respectively. The ratio of the sample OD to
positive control OD (S/P%) was calculated for each sample: S/P% =
(OD sample - OD negative control)  (OD positive control - OD
negative control) ¥ 100.An S/P% < 30%was considered to be negative;
between 30% and 50% was considered to be weak positive; between
50% and 70%was considered to be positive;>70%was considered to be
stronglypositive.Serawith anS/P%>50% to either or bothphase II and
phase I antigens were considered to be positive.
Statistical analyses
ANOVA was performed on seasonality data to determine whether
differences in beef cattle seropositivity at various times of year were
statistically significant.
Results
Screening of bovine sera from abattoir
Of the 720 abattoir samples collected, 67 (9.3%, 95% confidence inter-
val (CI) 9.29–9.32%) and 34 (4.7%, 95% CI 4.70–4.73%) were positive
for antibodies to phase II or phase I C. burnetii antigen, respectively.
Of these, 28 (38.9%) were positive for both phases, with 82.3% of beef
cattle positive for phase II also positive for phase I. A total of 73
(10.1%, 95% CI 10.1–10.2%) samples were seropositive for either or
both antigenic phases.A further breakdown of seropositivity is shown
in Table 1. Positive samples were returned from 40% of the properties.
Approximately 70% of the phase II and 80% of the phase I positive
samples came from a single property in the Townsville Shire, record-
ing a high seroprevalence of 26.7% and 13.7% for phase II and phase
I, respectively.
Screening of bovine sera from breeders and heifers
Of the 1344 samples tested, 134 (9.9%, 95% CI 9.9–10.0%) and 145
(10.7%, 95% CI 10.7–10.8%) were positive for antibodies to phase II or
phase I C. burnetii antigen, respectively. Of these, 35 (2.6%) were
positive for both phases. A total of 280 (20.8%, 95% CI 20.8–20.9%)
samples were seropositive to either or both antigenic phases.A further
breakdown of seropositivity is shown in Table 1. Positive samples were
returned from 78.2% of the properties. Seropositivity ranged from
0.0% to 65.4% for antibodies to phase II antigen and from 0.0% to
46.7% for antibodies to phase I antigen.
Overall seropositivity in cattle
Overall seropositivity to phase II and phase I C. burnetii antigens in
beef cattle sampled (n = 1835) in Queensland was 10.0% (95% CI
9.9–10.0%) and 9.2% (95% CI 9.20–9.22%), respectively. Seropositiv-
ity to either or both antigenic phases of C. burnetii was 16.8% (95% CI
16.7–16.8%). The percentage of samples positive for both phase II and
phase I differed between the two sample sets, with abattoir samples
having a higher percentage of antibodies to both antigens compared
with the breeder and heifer samples. Samples were obtained from 58
mobs on 56 beef cattle properties located in 24 districts across Queen-
sland. These districts covered most of the statistical divisions of
Queensland, with the exception of the south-east corner. Seropositiv-
ity varied both between and within many of the districts and regions
sampled (Table 2). The greatest variation was observed in the Fitzroy,
Central West and Mackay regions.
Seasonality of seropositivity
Cattle seropositivity to both antigenic phases of C. burnetii at the time
of pregnancy testing was lower in the earlier months of the year
(March/April), higher mid-year (May/June) and increasingly higher
in the later months of the year (August/September) (Figure 1). Similar
trends were seen for seropositivity to both phase II and phase I anti-
gens (Figure 1).
Discussion
The current study demonstrated that the seroprevalence of C. burnetii
in the bovine population sampled was approximately 10.0% (95% CI
9.9–10.0%) for phase II and 9.2% (95% CI 9.20–9.22%) for phase I,
with an overall seropositivity of 16.8% (95%CI 16.7–16.8%).Although
this is within the range of reported seroprevalences of C. burnetii in
cattle in other parts of the world, it is still considered high. In this
study, antibodies to both phase II and phase IC. burnetii antigens were
detected by ELISA. This is the first known study to use an Australian
C. burnetii isolate as a source of antigen in an ELISA. A recent Aus-
tralian study conducted in Western Australia used a commercial Q
fever ELISA developed in Europe (IDEXX CHEKiT Q fever ELISA)
and reported very low numbers of positive samples in beef cattle and
sheep samples, despite relatively high numbers of positive samples
being detected in kangaroo samples from the same areas.4 Differences
in antigen production, such as the use of whole cell antigen, lysates or
chemical extracts, may account for the variation in ELISA results.
Also, it is possible that there are antigenic differences between
C. burnetii isolates from Europe and Australia that account for the
variations in ELISA results.
Table 1. Breakdown of seropositivity in abattoir samples and samples collected from breeders and heifers
Seropositivity
Negative Weakly positive Positive Strongly positive
(S/P% < 30%) (S/P% 30–50%) (S/P% 50–70%) (S/P% > 70%)
Phase II Phase I Phase II Phase I Phase II Phase I Phase II Phase I
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Abattoir (n = 720) 653 (90.7) 686 (95.3) 43 (6.0) 7 (1.0) 10 (1.4) 17 (2.4) 14 (1.9) 7 (1.0)
Breeders and heifers (n = 1344) 1210 (90.0) 1199 (89.2) 62 (4.6) 77 (5.7) 40 (3.0) 38 (2.8) 32 (2.4) 30 (2.2)
S/P%, ratio of the sample’s optical density (OD) to positive control OD, calculated for each sample: S/P% = (OD sample - OD negative control)
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In serological studies of Q fever, high antibody titres to phase II
antigen indicate acute infection and high antibody titres to phase I
indicate chronic infection. The significance of antibody development
to each antigenic phase of C. burnetii in animal infections has not been
fully established.33 However, some studies have suggested that the
presence of antibodies to phase II antigen in animal sera indicates
recent infection.34,35 Serological tests for the presence of antibodies
against C. burnetii in animals are unable to determine whether an
animal is actively shedding the organism.34 Animals can remain sero-
positive for long periods after the initial infection has been cleared and
some can seroconvert without shedding C. burnetii. Alternatively,
animals may begin to shed the organism prior to the production of
antibodies and some infected animals never demonstrate seroconver-
sion.36 In this study, abattoir samples had a higher percentage of anti-
bodies to both antigens compared with the breeder and heifer
samples. The significance of this observation could not be determined
in this study and further investigation is required to determine
whether seropositivity to both antigenic phases in beef cattle is indica-
tive of recent or chronic infection with C. burnetii.
Levels of seropositivity to C. burnetii antigens in the beef cattle tested
varied according to the time of year. Seasonality of antibody levels
has also been demonstrated in sheep in North America in association
with lambing.16 This effect is unlikely to be seen in beef cattle because
year-round breeding occurs in most areas. However, as large quan-
tities of C. burnetii can be shed during parturition it may be possible
for infection of other species to occur, particularly in areas where
primary production of both cattle and sheep is concentrated. In
Queensland, lambing is unlikely to be a factor in the seasonality of
antibody levels observed in cattle, because of the similarity in anti-
body level trends in beef cattle in both the northern and southern
regions of Queensland despite the differences in lambing season
between the regions. Generally, in the areas south of the central-west
region lambing occurs during July–September, whereas in the areas
north of the central-west, lambing occurs during February–April.37
The rise in seropositivity to C. burnetii in the later months of the year
may be related to the increase in tick populations. In Queensland,
ticks are predominately in the nymphal phase during winter, with the
emergence of adults and increase in tick numbers occurring during
spring.38
In conclusion, the ELISA technique developed in this study enabled
large numbers of animal sera to be screened at a relatively low cost per
sample. As there are no published studies on the exposure of animals
to C. burnetii in this region, this investigation is a step towards under-
standing the epidemiology of Q fever in Queensland. The evidence of
C. burnetii infection in beef cattle may have public health implications
for occupational exposure of veterinarians and primary producers
and for the proximity of beef cattle properties to residential areas
in regional Queensland. Further investigation of additional potential
Table 2. Beef cattle seropositivity in various statistical divisions of Queensland, Australia
Region Cattle (n) Samples (n) Seropositivity (%) (95% CI)
Phase II Phase I Total
Far North Queensland 756,400 96 26.4 (17.5–35.3) 13.1 (8.7–17.5) 31.1 (27.9–34.3)
Northern Queensland 1,073,600 539 12.1 (12.0–12.1) 5.0 (4.9–5.0) 14.8 (14.8–14.9)
North-west Queensland 1,915,400 350 9.4 (9.4–9.5) 13.1 (13.1–13.2) 20.3 (20.2–20.4)
Mackay 1,232,200 30 0.0 (0.0-0.4) 33.3 (32.7–25.1) 33.3 (32.7–25.1)
Central-west Queensland 1,012,600 88 9.1 (9.0–9.3) 11.4 (10.7–11.6) 15.9 (15.8–16.2)
Fitzroy 2,354,600 55 5.5 (5.4–5.7) 16.4 (16.2–16.9) 20.0 (19.8–20.6)
Wide Bay/Burnett 939,400 245 4.9 (4.8–4.9) 3.7 (3.6–3.7) 8.6 (8.5–8.6)
Darling Downs 1,390,800 240 10.0 (9.9–10.1) 10.4 (10.1–10.5) 17.5 (17.4–17.6)
South-west Queensland 1,146,800 155 2.6 (2.5-2.6) 9.7 (9.6–9.8) 11.6 (11.5–11.7)
Total 11,821,800 1835 10.0 (10.0–10.0) 9.2 (9.2–9.2) 16.8 (16.7–16.8)
CI, confidence interval.
Figure 1. Seasonality of seropositivity to Coxiella burnetii antigens in
beef cattle in Queensland. Seropositivity to either or both phase II and
phase I antigens of C. burnetii in various months of the year is shown.
Horizontal bars represent mean for each period and vertical represent
standard error of themean for each period. Statistically significant differ-
ences were found between March/April and May/June (P < 0.10), March/
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reservoirs, such as other livestock, companion animals and wildlife, is
needed to determine their role in Q fever.
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